v3.25.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2024
Summary of Significant Accounting Policies [Abstract]  
Schedule of Exchange Rates

Translation of amounts from RMB into US$ has been made at the following exchange rates for the respective periods:

 

   December 31,
2024
   December 31,
2023
 
Balance sheet items, except for equity accounts   7.2993    7.0999 
           

 

   For the Years Ended December 31, 
   2024   2023   2022 
Items in the statements of operations and comprehensive loss, and statements of cash flows   7.1957    7.0809    6.729 
                
Schedule of Property and Equipment Estimated Useful Lives Depreciation is computed using the straight-line method with residual value rate of 5% based on the estimated useful lives as follows:
Land and buildings   7 - 21 years
Office equipment   3 years
Vehicle   4 years
Leasehold improvements   5 years
Schedule of Amortized Over their Estimated Useful Lives

Separately identifiable intangible assets that have determinable lives continue to be amortized over their estimated useful lives using the straight-line method based on their estimated useful lives as follows:

 

Trademarks   10 years
License   10 years
Software   3 - 10 years
Schedule of Disaggregation of Our Revenue

The following table identifies the disaggregation of our revenue for the years ended December 31, 2024, 2023 and 2022, respectively.

 

   For the Years Ended
December 31,
 
   2024   2023   2022 
Medical training and education services  $7,704,812   $6,385,735   $6,604,487 
Patient management services in patient-aid projects   5,910,370    3,998,455    6,288,602 
Sales of patented drugs   2,151,809    9,027,211    1,216,096 
Other revenues   97,782    22,544    42,331 
Total  $15,864,773   $19,433,945   $14,151,516